Montelukast Post-Marketing Comparative Study With Ketotifen (0476-379)

NCT00446056 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

188

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: MK0476, montelukast sodium / Duration of Treatment: 4 Weeks
DRUG: Comparator: ketotifen / Duration of Treatment: 4 Weeks

Sponsor

Organon and Co